期刊文献+

异基因造血干细胞移植后侵袭性真菌病危险因素分析 被引量:3

Risk factors of invasive fungal disease after allogeneic hematopoietic stem cell transplantation
下载PDF
导出
摘要 目的了解血液系统恶性疾病患者异基因造血干细胞移植(allo-HSCT)术后侵袭性真菌病(IFD)的发病率、危险因素。方法选择2007年1月至2013年11月于重庆医科大学附属第一医院HSCT中心接受allo-HSCT的患者82例,按照我国IFD诊断标准进行回顾性分析。结果 82例allo-HSCT术后患者,共诊断22例IFD,发生率为26.83%,其中确诊IFD者5例(22.73%),临床诊断者7例(31.82%),拟诊者10例(45.45%)。3、6、12个月的累积发病率分别为11.10%、15.30%、22.60%。多因素分析中,移植前真菌感染史、HLA配型不合是IFD早期的危险因素;广谱抗菌药物使用、大剂量激素使用为IFD晚期的危险因素。结论 IFD是allo-HSCT术后严重并发症,其发生率和病死率均较高。HLA配型不合、移植前真菌感染史、持续中性粒细胞缺乏、大剂量激素使用、广谱抗菌药物使用、慢性移植物抗宿主病(GVHD)是IFD的危险因素。 Objective To examine the risk factors and incidence of invasive fungal disease(IFD)in recipients after allogeneic hematopeietic stem cell transplantation(allo-HSCT). Methods We performed a study of eighty-two patients undergoing allo-HSCT from January 2007 to November 2013. We defined IFD using standard criteria and selected proven, probable and possible cases for retrospective review. Results For 82 cases,22 cases of IFD(26.83%)were identified,including 5 proven IFD(22.73%) ,7 Probable IFD(31.82 % )and 10 possible IFD(45.45 %)cases respectively. The cumulative incidence rate of IFD for 3 months, 6 months and 12 months was 1 1.10 % 15.30 %, 22.60 % respectively. Univariate analysis showed that neutrophil d0. 5 ×109/L more than 14 days, previous history of IFD as risk factors of early IFD after allo-HSCT, and previous history of IFD, glueocorticosteroid use, antibiotics use, chronic GVHD as risk factors of late IFD. In multivariate analysis, the early risk factors were HLA unmatched, previous history of IFD, while glucocorticosteroid use,antibiotics use were risk factors of late IFD. Conclusion IFD was one of the severe complica- tions after allo-HSCT with high incidence and mortality. Its risk factors were HLA unmatched, previous history of IFD, neutrophil〈0. 5 × 109/L more than 14 days,glucoeorticosteroid use,antibiotics use,chronic GVHD.
出处 《重庆医学》 CAS 北大核心 2015年第21期2904-2906,共3页 Chongqing medicine
基金 重庆市科委课题项目(cstc2013jjB0145)
关键词 异基因造血干细胞移植 侵袭性真菌病 危险因素 allogeneic hematopoietic stem cell transplantation invasive fungal disease risk factors
  • 相关文献

参考文献14

  • 1Kawazu M, Kanda Y, Nannya Y, et al. Prospective com- parison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galaetomannan, and a (1,3)-heta-D-gluean test in weekly screening for invasive aspergillosis in patients with hema- tological disorders [J]. J Clin Microbiol, 2004, 42 (6) : 2733-2741.
  • 2Martino R, Subira M, Rovira M, et al. Invasive fungal in- fections after allogeneic peripheral blood stem cell trans- plantation:Incidence and risk factors in 395 patients[J]. Br J Haematol,2002,116(2) :475-482.
  • 3Neofytos D, Horn D, Anaissie E, et al. Epidemiology and outcome of invasive fungal infection in adult hematopoiet- ic stem cell transplant recipients:Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance regis- try[J]. Clin Infect Dis,2009,48(3) :265-273.
  • 4Brunstein CG, Weisdorf DJ, DeFor T, et al. Marked in- creased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmye- loablative conditioning prior to unrelated umbilical cord blood transplantation [J]. Blood, 2006, 108 (8): 2874- 2880.
  • 5Girmenia C, Raiola AM, Piciocchi A, et al. Incidence and outcome of invasive fungal disease after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) [J]. Biol Blood Marrow Transplant,2014,20(6) :872-880.
  • 6Omer AK, Ziakas PD, Anagnostou T, et al. Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience[J]. Boil Blood Marrow Transplant,2013,19 (8) : 1190-1196.
  • 7黄晓军.血液病/恶性肿瘤患者侵袭性真菌病的诊断标准与治疗原则(第四次修订版)[J].中华内科杂志,2013,52(8):704-709. 被引量:207
  • 8Kurosawa M, Yonezumi M, Hashino S, et al. Epidemiolo- gy and treatment outcome of invasive fungal infections in patients with hematological malignancies[J]. Int J Hema- tol, 2012,96 (6) : 748-757.
  • 9Herhrecht R, Letscher-Bru V, Oprea C, et al. Asperjillus galactomannan detection in the diagnosis of invasive as- pergillosis in cancer patients [J]. J Clin 0ncol, 2002,20 (7) : 1898-1906.
  • 10Maziarz RT, McLeod A,Chen M, et al. Outcomes of allo- geneie HSCT for patients with hematologic malignancies (AML,ALL, MDS, CML) with and without pre-existing fungal infeetions:A CIBMTR study[J]. Biol Blood Marr- row Transplant,2013,19(7) :S124-125. gene therapy is calprotectindependent -J. J Allergy Clin Immunol, 2011,127 (5) : 124321252.

二级参考文献22

  • 1Lionakis M S , Kontoyiannis D P. Glueocorticoids and invasive fungal infections[J]. Lancet,2003,362(29) : 1828-1838.
  • 2Shimoyama M, Shimmura S, Tsubota K, et al. Suppression of nuclear factor kappa B and CD18-mediated leukocyte adhesion to the corneal endothelium by dexamethasone [ J ]. Invest Oph- thalmol Vis Sci, 1997,38( 11 ) : 2427-2431.
  • 3Ray KP, Farrow S, Daly M, et al. Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids [ J ]. Biochem J, 1997, 328 ( 3 ) : 707-715.
  • 4Prasada R, Devauxb F, Dhamgayea S, et al. Response of patho- genic and non-pathogenic yeasts to steroids[ J]. J Steroid Bio- ehem Mol Biol, 2012,129 (1) :61-69.
  • 5Lanza L, Scudeletti M, Monaco E, et al. Possible differences in the mechanism(s) of action of different glueocorticoid hormone compounds[J].Ann N Y Aead Sei, 1999, 876 (1) : 193-197.
  • 6DeRijk RH, Sehaaf M, de Kloet ER. Glucoeorticoid receptor variants: clinical implications. J Steroid Biochem Mol Biol, 2002, 81 ( 1 ) : 103-122.
  • 7Peter E, Bakfi F, Ball DM, et al. Invasive pulmonary filamen- tous fungal infection in a patient receiving inhaled corticosteroid therap[J]. Clin Infect Dis,2002,35 ( 1 ) : 54-56.
  • 8Man" KA, Carter RA, Boeekh M, et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiol- ogy and risk factors[ J]. Blood,2002,100(22) : 43584366.
  • 9Klein NC, Go Ch, Cunha BA. Infections associated with steroid use[J].Infect Dis Clin North Am,2001.15(3) : 423-432.
  • 10Dojcinovic I, Richter M. Mucormycoses: serious complication of high-dose eorticosteroid therapy for traumatic optic neuropa- thy[J]. Int J Oral Maxillofac Surg,2008,37(4) : 391-394.

共引文献222

同被引文献30

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部